Literature DB >> 14671

NADPH-cytochrome P-450 reductase from rat liver: purification by affinity chromatography and characterization.

J D Dignam, H W Strobel.   

Abstract

(NADPH)-cytochrome P-450 reductase was purified to apparent homogeneity by a procedure utilizing nicotinamide adenine dinucleotide phosphate (NADP)-Sepharose affinity column chromatography. The purified flavoprotein has a molecular weight of 79 700 and catalyzes cytochrome P-450 dependent drug metabolism, as well as reduction of exogenous electron acceptors. Aerobic titration of cytochrome P-450 reductase with NADPH indicates that an air-stable reduced form of the enzyme is generated by the addition of 0.5 mol of NADPH per mole of flavin, as judged by spectral characteristics. Further addition of NADPH causes no other changes in the absorbance spectrum. A Km value for NADPH of 5 micron was observed when either cytochrome P-450 or cytochrome c was employed as electron acceptor. A Km value of 8 +/- 2 micron was determined for cytochrome c and a Km of 0.09 +/- 0.01 micron was estimated for cytochrome P-450.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 14671     DOI: 10.1021/bi00625a014

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  22 in total

1.  14-3-3 protein is a regulator of the mitochondrial and chloroplast ATP synthase.

Authors:  T D Bunney; H S van Walraven; A H de Boer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  A quantitative histochemical study of NADPH-ferrihemoprotein reductase activity.

Authors:  C J Van Noorden; R G Butcher
Journal:  Histochem J       Date:  1986-07

3.  Interactions of 8-anilino-1-naphthalenesulfonic acid (ANS) and cytochrome P450 2B1: role of ANS as an effector as well as a reporter group.

Authors:  X C Yu; H W Strobel
Journal:  Mol Cell Biochem       Date:  1996-09-20       Impact factor: 3.396

4.  Purification and characterization of the NADPH-cytochrome P-450 (cytochrome c) reductase from higher-plant microsomal fraction.

Authors:  I Benveniste; B Gabriac; F Durst
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

5.  Differences in Methadone Metabolism by CYP2B6 Variants.

Authors:  Sarah Gadel; Christina Friedel; Evan D Kharasch
Journal:  Drug Metab Dispos       Date:  2015-04-20       Impact factor: 3.922

6.  Human colon tumor cell line LS174T drug metabolizing system.

Authors:  D K Hammond; H W Strobel
Journal:  Mol Cell Biochem       Date:  1990-03-27       Impact factor: 3.396

7.  The drug metabolism systems of liver and liver tumors: a comparison of activities and characteristics.

Authors:  H W Strobel; J D Dignam; S E Saine; W F Fang; P M Fennell
Journal:  Mol Cell Biochem       Date:  1978-12-22       Impact factor: 3.396

8.  Generation of oxygen free radicals during the metabolism of cyclosporine A: a cause-effect relationship with metabolism inhibition.

Authors:  F Serino; J Grevel; K L Napoli; B D Kahan; H W Strobel
Journal:  Mol Cell Biochem       Date:  1993-05-26       Impact factor: 3.396

9.  4-Hydroxylation of estrogens as marker of human mammary tumors.

Authors:  J G Liehr; M J Ricci
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

10.  Vitamin C and alpha-naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI rats.

Authors:  Sarah M Mense; Bhupendra Singh; Fabrizio Remotti; Xinhua Liu; Hari K Bhat
Journal:  Carcinogenesis       Date:  2009-04-30       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.